Cleared Traditional

K182905 - UniPulse

K182905 is an FDA 510(k) clearance for UniPulse, manufactured by Seaward Group. The device is a Class 2 Cardiovascular device with product code DRL cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K182905 · Seaward Group · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
59d
Days
Class 2
Risk

K182905 is an FDA 510(k) clearance for the UniPulse. Classified as Tester, Defibrillator (product code DRL), Class II - Special Controls.

Submitted by Seaward Group (Peterlee, GB). The FDA issued a Cleared decision on December 14, 2018 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5325 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Seaward Group devices

FDA 510(k) Submission Details - K182905

510(k) Number K182905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 2018
Decision Date December 14, 2018
Days to Decision 59 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 125d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRL Device Classification - Class 2, Special Controls

Product Code DRL Tester, Defibrillator
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5325
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Steurer Consulting Group
Robert Steurer

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRL Tester, Defibrillator

Devices cleared under the same product code (DRL) and FDA review panel - the closest regulatory comparables to K182905.
Delta 3300
K190437 · Netech Corporation · Aug 2019
MODELS QED-6, 6M AND 6H DEFIBRILLATOR ANALYZER WITH OPTIONAL UNIVERSAL PACEMAKER LOAD ADAPTER
K954391 · Bio-Tek Instruments, Inc. · Nov 1995
DEFIBRILLATOR ANALYZER MODEL QED-5
K904159 · Bio-Tek Instruments, Inc. · Mar 1991
DEFIBRILLATOR INTERAL PADDLE TEST LOAD
K790394 · Physio-Control Corp. · Mar 1979
CARDIAC CARE Q/C TEST KIT
K782033 · Instrumentation Laboratory CO · Dec 1978